Lindbrook Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$6.82K Sell
195
-116
-37% -$4.6K ﹤0.01% 1822
2024
Q4
$13.8K Hold
311
﹤0.01% 1476
2024
Q3
$13.6K Buy
311
+8
+3% +$301 ﹤0.01% 1513
2024
Q2
$8.2K Buy
303
+285
+1,583% +$8.25K ﹤0.01% 1742
2024
Q1
$526 Sell
18
-225
-93% -$6.82K ﹤0.01% 2512
2023
Q4
$9.14K Sell
243
-364
-60% -$13.4K ﹤0.01% 1597
2023
Q3
$27.3K Sell
607
-323
-35% -$19.6K ﹤0.01% 915
2023
Q2
$68.5K Hold
930
0.01% 607
2023
Q1
$54.6K Buy
930
+316
+51% +$17.4K 0.01% 665
2022
Q4
$31K Sell
614
-204
-25% -$12.3K ﹤0.01% 870
2022
Q3
$71K Buy
818
+101
+14% +$10.6K 0.01% 542
2022
Q2
$82K Sell
717
-128
-15% -$14.7K 0.01% 496
2022
Q1
$109K Buy
845
+3
+0.4% +$432 0.02% 439
2021
Q4
$152K Buy
842
+767
+1,023% +$133K 0.02% 377
2021
Q3
$11K Hold
75
﹤0.01% 967
2021
Q2
$11K Hold
75
﹤0.01% 1021
2021
Q1
$10K Hold
75
﹤0.01% 1025
2020
Q4
$9K Hold
75
﹤0.01% 961
2020
Q3
$6K Hold
75
﹤0.01% 1045
2020
Q2
$5K Hold
75
﹤0.01% 1095
2020
Q1
$5K Buy
+75
New +$5.98K ﹤0.01% 1007

Other funds holding OMCL

Lindbrook Capital's OMCL Position: Q1 2025 in Review

Lindbrook Capital reduced its Omnicell (OMCL) stake by 37% in Q1 2025, selling an estimated $4.6K and leaving 195 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Lindbrook Capital first reported a position in OMCL in Q1 2020 and has held it in 21 quarters since. The position peaked at $152K in Q4 2021. 274 funds tracked by Wall St. Rank hold OMCL as of Q1 2025.

  • Lindbrook Capital held 195 shares of Omnicell worth $6.82K as of Q1 2025.
  • Lindbrook Capital sold 116 Omnicell shares in Q1 2025, an estimated $4.6K.
  • Omnicell made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1822 holding.
  • Lindbrook Capital first reported a position in Omnicell in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Omnicell position peaked at $152K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Omnicell as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.